Skip to main content

MEDIASTINAL SEMINOMA

Tracking # 20-831601

$99999.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

MEDIASTINAL SEMINOMA IS A MALIGNANT GERM CELL TUMOR IN THE MEDIASTINUM. THE TUMOR USUALLY OCCURS IN THE ANTERIOR-SUPERIOR MEDIASTINUM IN MALES AGED 20-40 YEARS OLD. THE FIRST-LINE TREATMENT IS WITH CISPLATIN BASED CHEMOTHERAPY. TO AVOID THE HIGH MORBIDITY AND MORTALITY ASSOCIATED WITH THIS CONDITION, IT MUST BE PROMPTLY DIAGNOSED AND TREATED BY A MULTIDISCIPLINARY TEAM CONSISTING OF MEDICAL ONCOLOGISTS, RADIATION ONCOLOGISTS, AND THORACIC SURGEONS. WHEN TREATMENT IS STARTED EARLY SURVIVAL RATES ARE > 90% 5 YEAR SURVIVAL.

Subject areas

This course counts toward the state boards and subject areas below.

Florida Board of Osteopathic Medicine

Osteopathic Physician

1h General